Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | BRD-K30748066 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.3 |
mRNA | BRD-K55473186 | CTRPv2 | pan-cancer | AAC | 0.057 | 0.3 |
mRNA | quizartinib | CTRPv2 | pan-cancer | AAC | -0.047 | 0.3 |
mRNA | EX-527 | GDSC1000 | pan-cancer | AAC | -0.04 | 0.3 |
mRNA | CIL55 | CTRPv2 | pan-cancer | AAC | -0.08 | 0.3 |
mRNA | BRD-K42260513 | CTRPv2 | pan-cancer | AAC | 0.07 | 0.3 |
mRNA | OSI-906 | CTRPv2 | pan-cancer | AAC | 0.044 | 0.3 |
mRNA | bid1870 | gCSI | pan-cancer | AAC | 0.057 | 0.3 |
mRNA | GSK1059615 | CTRPv2 | pan-cancer | AAC | 0.055 | 0.3 |
mRNA | Nilotinib | CCLE | pan-cancer | AAC | -0.062 | 0.4 |